Comparative Phylogeography of Medicinal Plants Across Biogeographic Regions
Table Of Contents
Chapter ONE
INTRODUCTION
- 1.1Introduction
- 1.2Background of the Study
- 1.3Statement of the Problem
- 1.4Aim and Objectives of the Study
- 1.5Research Questions
- 1.6Research Hypotheses
- 1.7Significance of the Study
- 1.8Scope and Delimitation of the Study
- 1.9Limitations of the Study
- 1.10Organisation of the Study
- 1.11Operational Definition of Terms
Chapter TWO
LITERATURE REVIEW
- 2.1Conceptual Review: Defining Phylogeography in Medicinal Plants Across Biogeographic Regions
- 2.2Conceptual Review: Genetic Markers and Their Relevance to Plant Biogeography
- 2.3Conceptual Review: Biogeographic Regions and Their Floristic Barriers in Medicinal Plant Distribution
- 2.4Theoretical Framework: Isolation by Distance and its Extensions in Phylogeography
- 2.5Theoretical Framework: n-Dimensional Niche and Coalescent-based Approaches
- 2.6Empirical Review: Phylogeographic Patterns in Widely Used Medicinal Plant Complexes
- 2.7Empirical Review: Seed Dispersal Mechanisms and Landscape Connectivity in Therapeutic Species
- 2.8Empirical Review: Climate Change Effects on Phylogeography of Medicinal Plants
- 2.9Empirical Review: Human Activities, Trade Routes, and Phytogeographic Signals in Medicinal Plants
- 2.10Gaps in the Phylogeographic Literature on Medicinal Plants Across Regions
- 2.11Conceptual Model/Review Synthesis: Integrating Genetic, Ecological, and Biogeographic Data
- 2.12Summary of the Review and Implications for the Present Study
Chapter THREE
RESEARCH METHODOLOGY
- 3.1Research Design: Comparative Cross-Regional Phylogeography of Medicinal Plants
- 3.2Philosophical Paradigm: Interpretivist-Constructivist Alignment in Genetic Data Interpretation
- 3.3Population of the Study: Target Medicinal Plant Species with Widespread Regional Presence
- 3.4Sample Size and Sampling Technique: Stratified Regional Sampling Across Biogeographic Zones
- 3.5Sources and Instruments of Data Collection: Field Sampling, Herbarium Records, and Genomic Sequencing Data
- 3.6Validity and Reliability of Instruments: Marker Validation, Replication, and Cross-Protocol Consistency
- 3.7Data Collection Procedures: DNA Extraction, Sequencing, and Environmental Metadata Capture
- 3.8Data Processing and Bioinformatics Pipelines: Sequence Alignment and Variant Calling
- 3.9Model Specification or Analytical Framework: Phylogeographic Statistical Models and Coalescent Analyses
- 3.10Ethical Considerations: Benefit Sharing, Access to Genetic Resources, and Permits
- 3.11Data Management and Reproducibility Plan
Chapter FOUR
DATA PRESENTATION AND ANALYSIS
- ANALYSIS AND DISCUSSION OF FINDINGS
- 4.1Data Presentation: Regional Genetic Variation Maps for Each Medicinal Plant
- 4.2Descriptive Analysis: Haplotype Diversity and Regional Differentiation Metrics
- 4.3Hypotheses Testing: Population Structure Across Biogeographic Regions
- 4.4Phylogeographic Inference: Historical Demography and Migration Pathways
- 4.5Comparative Analysis: Cross-Regional Concordance and Discordance in Gene Flow
- 4.6Environmental Correlates: Climate and Habitat Factors Shaping Phylogeography
- 4.7Human Impact Analysis: Trade Routes and Ex Situ Germplasm Influence
- 4.8Interpretation of Results: Synthesis with the Literature Review
Chapter FIVE
SUMMARY, CONCLUSION AND RECOMMENDATIONS
- CONCLUSION AND RECOMMENDATIONS
- 5.1Summary of Findings
- 5.2Conclusion: Implications for Conservation and Sustainable Use of Medicinal Plants
- 5.3Contribution to Knowledge: Methodological and Theoretical Advances
- 5.4Recommendations for Policy and Practice
- 5.5Suggestions for Further Studies
Thesis Abstract
The study addresses the persistent gap in understanding how historical biogeography and contemporary ecological processes shape genetic diversity and population structure of medicinal plants with widespread pharmacological relevance. Despite extensive ethnobotanical use and high value for drug discovery, comparative phylogeographic patterns across biogeographic regions remain underexplored, limiting inferences about lineage diversification, local adaptation, and conservation prioritization. The aim is to elucidate how demographic history, climatic oscillations, and habitat connectivity have driven spatial genetic structure in selected medicinal taxa across distinct biogeographic realms. Specific objectives are to (i) assess intraspecific genetic diversity and population differentiation using plastid and nuclear markers, (ii) reconstruct species-level phylogeographic histories with coalescent-based inference, (iii) compare environmental and geographic correlates of genetic structure across regions using landscape genetics, (iv) evaluate congruence between phylogeographic patterns and known ethnobotanical distributions, and (v) generate region-wide conservation recommendations based on identified evolutionary lineages and refugia. The methodology adopts a comparative, cross-regional design focusing on five medicinal plant species representing diverse taxonomic groups and biogeographic histories. Population sampling comprises at least 40 populations per species, with 15–20 individuals per population, totaling approximately 600–800 samples per taxon. Field collection is complemented by herbarium vouchers and geo-referenced occurrence data from national botanical databases to ensure representative geographic coverage. Data collection employs both organellar (trnH-psbA, rbcL) and nuclear (ITS, low-copy nuclear loci) markers, complemented by genome-wide single-nucleotide polymorphism (SNP) data generated via Restriction-site Associated DNA Sequencing (RAD-seq) to capture fine-scale structure. Environmental variables (precipitation, temperature, land cover, elevation) are extracted from high-resolution climatic layers and remote sensing products to support landscape genetic analyses. Analytical procedures integrate multiple approaches. Sequence data are aligned and edited before estimating genetic diversity indices (haplotype/allelic richness, nucleotide diversity) and population differentiation (FST, G’ST) using Arlequin and GenAlEx. Population structure is inferred with STRUCTURE and Discriminant Analysis of Principal Components (DAPC). Phylogeographic inferences employ coalescent-based methods (BEAST for time-calibrated phylogenies, IMa2 for historical gene flow) to reconstruct divergence times and ancestral demography. Genome-wide SNP data are analyzed with PCA, admixture analysis, and outlier detection (Bayescan) to identify selection and to correlate genomic differentiation with environmental gradients. Landscape genetics frameworks are applied using resistance surfaces and circuit theory (Circuitscape) to evaluate isolation-by-distance and isolation-by-environment patterns, while Mantel tests and multiple regression on distance matrices (MRDM) quantify associations between genetic structure and geographic/climatic variables. The study also tests phylogeographic congruence across taxa with comparative methods and uses approximate Bayesian computation (ABC) to evaluate alternative historical scenarios. Expected findings include detection of region-specific refugia and lineage diversification corresponding to Pleistocene climate oscillations, with differential retention of ancestral haplotypes among regions. It is anticipated that nuclear markers will reveal higher gene flow relative to plastid markers in most species, while RAD-seq data will uncover cryptic structure reflecting microrefugia and adaptive divergence along elevational and climatic gradients. The study expects varying degrees of concordance between ethnobotanical usage patterns and genetic lineages, suggesting localized adaptation or cultural dissemination shaping current distributions. The contribution to knowledge lies in providing an integrative, cross-regional phylogeographic framework for medicinal plants, combining organellar and nuclear genomic data with landscape and environmental analyses to reveal processes shaping diversity and distribution. The findings will inform conservation strategies by identifying evolutionarily significant units, refugia, and migration corridors critical for maintaining genetic diversity and biocultural value. The research concludes that regional histories and contemporary landscapes jointly sculpt phylogeographic patterns, recommending region-specific ex-situ and in-situ conservation actions, sustainable harvesting guidelines, and integration of phylogeographic insights into bioprospecting policies.
Thesis Overview
This study investigates how medicinal plants with similar uses are distributed and related across different biogeographic regions, focusing on their historical movements, gene flow, and genetic diversity. The core idea is to understand how geography, climate history, and species interactions have shaped the genetic structure of medicinal plant populations, which in turn influences their availability, conservation status, and the reliability of traditional and modern medicinal use.
Why it matters: Many medicinal plants are collected from multiple regions, and their therapeutic properties can vary with genetics and environment. By revealing patterns of phylogeography—how genetic lineages are distributed across space—researchers can identify well-supported management units for conservation, detect regions that harbor unique genetic diversity, and assess whether similar ethnobotanical uses arise from shared ancestry or convergent adaptation.
What problem or gap it addresses: There is a lack of integrated studies that combine genetic data with biogeography and ethnobotany for medicinal plants. Few cross-regional comparisons exist that test whether regional genetic structuring aligns with traditional classifications of plant use, and whether past climate fluctuations or barriers such as mountains and rivers have driven population differentiation.
What the researcher will do, step by step:
- Select a set of 6–8 widely used medicinal plant species with broad geographic ranges spanning multiple biogeographic regions.
- Collect leaf samples from 20–30 populations per species, ensuring representation across habitats, altitudes, and land-use contexts (totaling roughly 600–900 samples).
- Extract DNA and sequence multiple genetic markers, including chloroplast regions for lineage history and nuclear markers (e.g., SNPs or microsatellites) for fine-scale structure.
- Compile ethnobotanical data on traditional uses from published literature and field interviews to relate genetic patterns to medicinal traits.
- Analyze genetic data with population genetics tools to estimate diversity, structure (STRUCTURE/ADMIXTURE or PCA), gene flow (MIGRATE-N or similar), and phylogeographic patterns (haplotype networks, S-DIVA or BEAST).
- Test hypotheses about historical biogeography using coalescent-based modeling and correlate genetic structure with environmental variables and biogeographic barriers.
- Integrate findings with ethnobotanical context to assess concordance between genetic lineages and medicinal use.
Expected contributions and outcomes: A cross-regional framework linking phylogeography to medicinal plant utility, identification of priority conservation units, and insights into the reliability of ethnobotanical knowledge across regions.
Possible implications: Improved strategies for sustainable harvesting, ex-situ conservation prioritization, and informed selection of genetic lineages for pharmacological studies.